skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 213,291  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Oncology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Material Type:
Article
Add to My Research

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Journal of clinical oncology, 2021-09, Vol.39 (27), p.2991-3001 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.03555 ;PMID: 34292792

Full text available

2
Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Material Type:
Article
Add to My Research

Colorectal Cancer Incidence Patterns in the United States, 1974-2013

JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8) [Peer Reviewed Journal]

The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. 2017 ;ISSN: 0027-8874 ;EISSN: 1460-2105 ;DOI: 10.1093/jnci/djw322 ;PMID: 28376186

Full text available

3
Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer
Material Type:
Article
Add to My Research

Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer

Journal of clinical oncology, 2016-06, Vol.34 (18), p.2157-2164 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2015.65.9128 ;PMID: 27138577

Full text available

4
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
Material Type:
Article
Add to My Research

Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

Leukemia, 2019-11, Vol.33 (11), p.2575-2584 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-019-0472-2 ;PMID: 30967620

Full text available

5
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Material Type:
Article
Add to My Research

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3773-3784 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01255 ;PMID: 32931399

Full text available

6
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Material Type:
Article
Add to My Research

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Clinical cancer research, 2021-10, Vol.27 (20), p.5586-5594 [Peer Reviewed Journal]

2021 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-21-0410 ;PMID: 33926918

Full text available

7
Breast cancer statistics, 2019
Material Type:
Article
Add to My Research

Breast cancer statistics, 2019

CA: a cancer journal for clinicians, 2019-11, Vol.69 (6), p.438-451 [Peer Reviewed Journal]

2019 American Cancer Society ;2019 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2019 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21583 ;PMID: 31577379

Full text available

8
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Material Type:
Article
Add to My Research

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50

Journal of clinical oncology, 2021-07, Vol.39 (21), p.2339-2349 [Peer Reviewed Journal]

2021 by American Society of Clinical Oncology 2021 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.00174 ;PMID: 33872070

Full text available

9
Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer
Material Type:
Article
Add to My Research

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Journal of clinical oncology, 2017-06, Vol.35 (17), p.1884-1890 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.71.7397 ;PMID: 28296582

Full text available

10
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
Material Type:
Article
Add to My Research

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Journal of clinical oncology, 2019-06, Vol.37 (18), p.1558-1565 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.00201 ;PMID: 31067138

Full text available

11
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Material Type:
Article
Add to My Research

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Journal of clinical oncology, 2020-01, Vol.38 (1), p.11-19 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02107 ;PMID: 31725351

Full text available

12
Cancer statistics, 2018
Material Type:
Article
Add to My Research

Cancer statistics, 2018

CA: a cancer journal for clinicians, 2018-01, Vol.68 (1), p.7-30 [Peer Reviewed Journal]

2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jan-Feb 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21442 ;PMID: 29313949

Full text available

13
Ovarian cancer statistics, 2018
Material Type:
Article
Add to My Research

Ovarian cancer statistics, 2018

CA: a cancer journal for clinicians, 2018-07, Vol.68 (4), p.284-296 [Peer Reviewed Journal]

2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Jul/Aug 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21456 ;PMID: 29809280

Full text available

14
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Material Type:
Article
Add to My Research

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

The Lancet Oncology, 2020-03, Vol.21 (3), p.335-337 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30096-6 ;PMID: 32066541

Digital Resources/Online E-Resources

15
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Material Type:
Article
Add to My Research

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

Neuro-oncology (Charlottesville, Va.), 2015-10, Vol.17 Suppl 4 (suppl 4), p.iv1-iv62 [Peer Reviewed Journal]

The Centers for Disease Control. Published by Oxford University Press on behalf of the Society for Neuro-Oncology in cooperation with the Central Brain Tumor Registry 2015 2015 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/nov189 ;PMID: 26511214

Full text available

16
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer
Material Type:
Article
Add to My Research

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer

Journal of clinical oncology, 2018-03, Vol.36 (8), p.773-779 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.9901 ;PMID: 29355075

Full text available

17
Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy
Material Type:
Article
Add to My Research

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Journal of clinical oncology, 2020-10, Vol.38 (29), p.3388-3397 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.20.00549 ;PMID: 32749941

Full text available

18
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
Material Type:
Article
Add to My Research

Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3261-3272 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.02750 ;PMID: 32663119

Full text available

19
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
Material Type:
Article
Add to My Research

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)

Journal of clinical oncology, 2020-06, Vol.38 (18), p.2053-2061 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03296 ;PMID: 32343640

Full text available

20
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer
Material Type:
Article
Add to My Research

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer

Journal of clinical oncology, 2020-05, Vol.38 (14), p.1569-1579 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.02503 ;PMID: 32160096

Full text available

Results 1 - 20 of 213,291  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (199,892)

Refine My Results

Creation Date 

From To
  1. Before 1969  (123)
  2. 1969 To 1981  (2,372)
  3. 1982 To 1994  (16,035)
  4. 1995 To 2008  (55,129)
  5. After 2008  (139,642)
  6. More options open sub menu

Subject 

  1. Humans  (212,694)
  2. Science & Technology  (209,553)
  3. Life Sciences & Biomedicine  (207,450)
  4. Middle Aged  (196,475)
  5. Female  (183,757)
  6. Aged  (159,887)
  7. Male  (149,588)
  8. Adult  (133,941)
  9. Biological And Medical Sciences  (64,592)
  10. Medical Sciences  (64,220)
  11. Aged, 80 And Over  (61,742)
  12. Tumors  (52,537)
  13. Prognosis  (51,307)
  14. Medicine  (42,342)
  15. Medicine & Public Health  (39,811)
  16. Retrospective Studies  (35,296)
  17. Cancer Research  (33,081)
  18. Treatment Outcome  (33,041)
  19. Neoplasm Staging  (32,018)
  20. More options open sub menu

Language 

  1. English  (213,148)
  2. Japanese  (34,462)
  3. Portuguese  (642)
  4. Spanish  (374)
  5. Russian  (163)
  6. Norwegian  (112)
  7. German  (103)
  8. Chinese  (80)
  9. French  (28)
  10. Korean  (10)
  11. Turkish  (5)
  12. Polish  (1)
  13. Swedish  (1)
  14. Danish  (1)
  15. Italian  (1)
  16. Serbian  (1)
  17. Catalan  (1)
  18. More options open sub menu

Searching Remote Databases, Please Wait